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a b s t r a c t
Chronic arsenic toxicity is a global health problem that affects more than 100 million people
worldwide. Long-term health effects of inorganic sodium arsenite in drinking water may result
in skin, lung and liver cancers and in severe neurological abnormalities. We investigated in the
present study whether sodium arsenite affects signaling pathways that control cell survival,
proliferation and neuronal differentiation of human neural stem cells (NSC). We demonstrated
that the critical signaling pathway, which was suppressed by sodium arsenite in NSC, was the
protective PI3K–AKT pathway. Sodium arsenite (2–4 mM) also caused down-regulation of
Nanog, one of the key transcription factors that control pluripotency and self-renewal of stem
cells. Mitochondrial damage and cytochrome-c release induced by sodium arsenite exposure
was followed by initiation of the mitochondrial apoptotic pathway in NSC. Beside caspase-9 and
caspase-3 inhibitors, suppression of JNK activity decreased levels of arsenite-induced apoptosis
in NSC. Neuronal differentiation of NSC was substantially inhibited by sodium arsenite exposure.
Overactivation of JNK1 and ERK1/2 and down-regulation of PI3K–AKT activity induced by
sodium arsenite were critical factors that strongly affected neuronal differentiation. In conclu-
sion, sodium arsenite exposure of human NSC induces the mitochondrial apoptotic pathway,
which is substantially accelerated due to the simultaneous suppression of PI3K–AKT. Sodium
arsenite also negatively affects neuronal differentiation of NSC through overactivation of
MEK–ERK and suppression of PI3K–AKT.
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Introduction
Chronic arsenic toxicity is a global environmental health problem
that affects millions of people from Bangladesh to the United
States. Arsenic is a transplacental carcinogen in rodents and
probably in humans [1,2]. Long-term health effects of exposure
to inorganic arsenite may result in skin, lung and liver cancers,
cardiovascular diseases and neurological abnormalities [3,4].
Furthermore, arsenic is a well-characterized teratogen in animal
models, inducing a general embryotoxicity and negatively affect-
ing embryonic neurogenesis [5]. In the United States, the EPA has
set the arsenic standard for drinking water as 10 ppb (10 mg/L) to
protect consumers served by public water systems from the
effects of arsenic exposure. Contaminated groundwater in some
parts of the world may contain arsenic at concentration as high
as 5 mg/L [6,7], being associated with substantial increased risk
for wide array of diseases including cancer. At biochemical levels,
sodium arsenite at high doses (45 mM) represents a general cell
poison acting as a sulfhydryl reagent, which binds to the free
thiol groups of numerous enzymes, inhibiting their functions and
also significantly depleting levels of glutathione (GSH) that
destroys the cell metabolism [8]. Furthermore, sodium arsenite
is a strong inducer of production of reactive oxygen species
causing oxidative stress, mitochondrial damage and a broad
range of pathological conditions. These complementary negative
actions of sodium arsenite finally result in the induction of cell
death [9–11]. Chronic arsenite exposure, which occurred in most
cases at lower doses (1–4 mM), could affect the crucial signaling
pathways, transcription factors and gene expression in different
types of cells, including stem cells.
The self-renewal of embryonic stem cells and the maintenance
of their pluripotency are dependent on multifactorial stimulation
of the cell signaling pathways by a combination of cytokines and
growth factors that regulate ‘‘stemness’’-specific gene expres-
sion. These genes encode key transcription factors Oct4, Sox2,
Nanog, Klf4 and c-Myc [12,13]. Transcription factors Sox2 and
Nanog [14] in concert with Ars2 (arsenic-resistance protein 2),
which was recently demonstrated as a transcriptional regulator
of Sox2 expression [15], play the central role in gene regulation
in multipotent neural stem cells (NSC), coordinating expression
of numerous genes and providing a dynamic suppression of the
differentiation program. To prove our hypothesis regarding
specific targets of sodium arsenite, which regulate self-renewal,
survival and differentiation of NSC, we elucidated the effects of
arsenite treatment on signaling pathways in human NSC with
special attention to regulation of protein levels of Sox2, Nanog
and Ars2.
During embryogenesis, transplacental arsenite exposure might
negatively affect proliferation and survival of embryonic NSC.
Furthermore, NSC also persist in two specialized niches in the
adult brain initiating adult neurogenesis that is critically impor-
tant for functional recovery in the brain after injury or disease
[14,16]. The blood brain barrier in healthy adults quite effec-
tively, but not absolutely, protects against arsenite trafficking in
the brain [17]. However, the blood brain barrier is not fully
developed until the age of six months in humans, making a
childs brain especially vulnerable to toxic exposure [18]. We
have suggested in the present study that arsenite exposure
might target both embryonic and postnatal neurogenesis via
interference and interaction with cell signaling pathways, includ-
ing induction of death signaling in human NSC.
There is evidence to indirectly support this suggestion. Animal
experiments demonstrated sensorimotor and cognitive behavioral
deficits in mice and rats after prolonged arsenic treatment [19].
Chronic arsenic exposure from drinking water negatively affected
neurobehavioral development in human adolescence [6]. The
epidemiological studies of human populations in Bangladesh
exposed to sodium arsenite in drinking water further revealed an
inverse association between arsenic dose and IQ performance [20].
We demonstrate in our study a differential response of several
signaling pathways to sodium arsenite exposure in NSC. We also
elucidate a mechanism of the apoptotic death induced by sodium
arsenite in NSC, involving the mitochondrial death pathway as the
main player. The maintenance of human NSC in cell culture is
ultimately dependent on the presence of several growth factors, such
as FGF2, EGF and IGF1/2 that are linked with the regulation of
expression of key transcription factors, Sox2 and Nanog [21].
Removing FGF2 and EGF from the cell culture media induced
neuronal differentiation [22]. A special interest was to investigate
the effects of sodium arsenite exposure on the neuronal pathway of
differentiation of human NSC. We demonstrate in this study that
chronic arsenic exposure dramatically and negatively affects the
neuronal pathway of differentiation of NSC based on the opposite
roles for ERK1/2 and JNK activation. Revealing a connection between
stem cell biology and environmental health studies will allow us to
better understand mechanisms of neurodegenerative diseases.
Materials and methods
Reagents
Sodium arsenite, fibronectin, laminin and polyornithine were
obtained from Sigma-Aldrich (St. Louis, MO, USA). PI3K inhibitor
LY294002, IKK inhibitor BMS345541, STAT3 inhibitor-6 S3I-201
(also known as NSC 74859), IGF-1R kinase inhibitor picropodo-
phyllin (PPP), PI3K inhibitor LY294002, MEK inhibitor U0126,
MAPK p38 inhibitor SB203580, JNK inhibitor SP600125 and
caspase inhibitors zVAD-fmk, LEHD and IETD were purchased
from Calbiochem (La Jolla, CA, USA).
Human embryonic neural stem cells in culture
Cryopreserved human embryonic neural stem cells (NSC) were
obtained from Gibco/Life Technologies (Carlsbad, CA, USA) as a
commercially available product (N7800-200). The cells were
derived from NIH approved H9 (WA09) human embryonic stem
cells. The cells were plated in 6-well culture plates coated with
fibronectin and incubated at 37 1C in complete growth medium
NSC/SFM, which contained serum-free DMEM/F12 supplemented
with 2 mM GlutaMAX, bFGF (20 ng/ml), EGF (20 ng/ml) and
StemPRO neural supplement (2%). All reagents were obtained
from Gibco/Life Technologies (Carlsbad, CA, USA).
Neuronal differentiation of human neural stem cells in
culture
Neural stem cells were plated on polyornithine- and laminin-
coated 6-well plates, which contained similarly coated cover
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slips, in complete NSC/SFM. After 2 days, neuronal differentiation
was initiated by neuronal differentiation media, which contain
Neurobasal medium, B-27 serum-free supplement (2%) and
2 mM GlutaMAX (Gibco/Life Technologies). Medium was chan-
ged every two days. A neuronal phenotype was confirmed using
immunofluorescence detection 10 days after initiation of
differentiation.
Immunocytochemistry analysis
Cells were fixed with 4% paraformaldehyde in PBS for 60 min.
Immunochemical staining was performed using standard proto-
cols. Cells were stained for the undifferentiated NSC marker,
nestin (using mAb fromMillipore, Temecula, CA, USA) and for the
neuronal marker, doublecortin using Ab from Cell Signaling,
(Danvers, MA, USA). Additional markers include Sox2, phospho-
(T202,Y204)-ERK, phospho-JNK, phospho-(S73)-cJun (using Abs
from Cell Signaling) and pyruvate dehydrogenase (using Ab from
Binding Site, UK). The secondary Abs were Alexa Fluor 594 goat
anti-mouse IgG and Alexa Fluor 488 goat anti-rabbit IgG from
Molecular Probes/Life Technologies (Carlsbad, CA, USA). A laser
scanning confocal microscope (Nikon TE 2000 with EZ-C1 soft-
ware, Tokyo, Japan) was used for immunofluorescence image
analysis.
Apoptosis studies
For induction of apoptosis, cells were exposed to sodium arsenite
(1–10 mM) alone or in the presence of small molecule inhibitors
of cell signaling pathways. Apoptosis was then assessed by PI
staining by quantifying the percentage of hypodiploid nuclei
(pre-G1) using FACS analysis or by quantifying the percentage of
Annexin-V-FITC-positive cells (BD Pharmingen, San Diego, CA).
Flow cytometric analysis was performed on a FACS Calibur flow
cytometer (Becton Dickinson) using the CellQuest program. The
trypan blue exclusion test was used for determination of cell
viability and total death levels.
Western blot analysis
Total cell lysates (50 mg protein) were resolved on SDS-PAGE, and
processed according to standard protocols. The monoclonal
antibodies used for Western blotting included: anti-b-actin
(Sigma, St. Louis, MO, USA); anti-caspase-8, anti-caspase-9, and
anti-caspase-3 (Cell Signaling, Danvers, MA, USA). The polyclonal
antibodies used included anti-phospho-p44/p42 MAP kinase
(T202/Y204) and anti-p44/p42 MAP kinase; anti-phospho-JNK
and anti-JNK1-3; anti-phospho-cJun (S73) and anti-cJun; anti-
phospho-AKT (S473) and anti-AKT; anti-phospho-p65 (S536)
NF-kB and anti-p65 NF-kB, anti-phospho-STAT3 (Y705) and
anti-STAT3; anti-phospho-FOXO3A (S253) and anti-FOXO3A;
anti-b-Catenin, anti-Oct4, anti-Sox2, anti-Nanog and anti-
PARP-1 (Cell Signaling, Danvers, MA, USA); anti-Ars2 (Santa Cruz
Biotechnology, CA, USA); anti-HO-1 (Enzo Life Sciences, Ply-
mouth Meeting, PA, USA). The secondary antibodies were con-
jugated to horseradish peroxidase; signals were detected using
the ECL system (Thermo Scientific, Rockford, IL, USA).
Statistical analysis
Data from four to five independent experiments were calculated
as means and standard deviations. Comparisons of results
between treated and control groups were made by the Students’
t-tests. A p-value of 0.05 or less between groups was considered
significant.
Results
Sodium arsenite modulates signaling pathways that
control self-renewal and survival of human neural stem
cells
In our study we address three main questions regarding effects of
sodium arsenite exposure on human NSC: (i) Does arsenite
treatment induce apoptotic pathways in NSC? (ii) Does arsenite
additionally accelerate pro-apoptotic commitment in NSC via
suppression of pro-survival pathways? (iii) What are the effects
of arsenite treatment on neuronal differentiation of NSC?
Characteristic features of human NSC include nuclear expres-
sion of key transcription factor Sox2 and cytoplasmic expression
of nestin, undifferentiated NSC/early neuroprogenitor cell marker
(Fig. 1A and B). Sodium arsenite treatment (1–4 mM) suppressed
logarithmic phase growth of adherent cultures of NSC (Fig. 1C)
and substantially increased levels of cell death in confluent
cultures (Fig. 1D). A significant difference in growth of control
and sodium arsenite treated (1–4 mM) cells was evident 1–3 days
after treatment. Furthermore, dose-dependent effects of arsenite
treatment on NSC survival were well pronounced for concentra-
tions 1 mM versus 4 mM. The resulting dramatic differences in
cell survival of the control and arsenite-treated NSC (48 h of
exposure) are demonstrated in Fig. 1D–F. Sodium arsenite
induced massive flotation of dead neural stem cells (Fig. 2A).
Finally, many human NSC died 24–48 h following arsenite
exposure (2–6 mM) in a dose-dependent manner via apoptotic
mechanism (Fig. 2B). Levels of total cell death were higher
compared to apoptotic levels (Fig. 2B, right column), indicating
a possible role for necrosis in a subpopulation of NSC after
sodium arsenite treatment.
To determine signaling pathways and regulatory proteins that
were targeted by sodium arsenite treatment of NSC with final
induction of apoptosis, we performed Western blot analyses of
total protein extracts of NSC before and after arsenite exposure
(Fig. 3). A distinguishing feature of arsenite treatment (6 h) was a
significant upregulation of levels of active forms of phospho-
ERK2 and phospho-JNK1 (while the level of active neuro-specific
JNK3 was actually down-regulated) that was followed by enor-
mous activation of cJun (Fig. 3A). Analysis of an immunofluor-
escent image confirmed upregulation of active phospho-ERK
levels upon arsenite treatment of human NSC (Fig. 3B). This
process was accompanied by a strong decrease in active
phospho-AKT levels and, consequentially, by a decrease of AKT-
dependent phosphorylation of FOXO3A (Fig. 3A) that could
additionally release proapoptotic activity of FOXA3A [23]. Total
beta-catenin protein levels were high and relatively stable during
the initial treatment of NSC by arsenite (Fig. 3A). Only a modest
decrease in b-catenin levels was observed 16 h after arsenite
exposure (see Fig. 4A). Furthermore, in contrast to embryonic
E X P E R I M E N T A L C E L L R E S E A R C H 3 1 9 ( 2 0 1 3 ) 8 7 5 – 8 8 7 877
Author's personal copy
stem cells after sodium arsenite exposure (data not shown),
activation of Stat3 via Tyr705 phosphorylation was not notably
affected by arsenic treatment of NSC (Fig. 3A). Interestingly, a
modest upregulation of Sox2 and Ars2 levels was actually
observed 6 h after arsenite treatment (Fig. 3A and C) that
coincided with cJun activation at these doses of arsenite. Indeed,
SP600125 (20 mM), a specific inhibitor of JNK, decreased levels of
active JNK–cJun that were induced by sodium arsenite, and
consequently down-regulated Ars2 and Sox2 levels (Fig. 3C).
Nanog protein levels were relatively stable after treatment with
1–4 mM arsenite for 6 h (Fig. 3A), but were substantially
decreased after treatment with 2–4 mM arsenite for 16 h (see
Fig. 4C). Nestin protein levels were gradually decreased after
arsenite treatment (Fig. 3A).
Furthermore, treatment with low doses of arsenite notably
increased phosphorylation of IKKa/b (inhibitor nuclear factor
kappa B kinase a/b) and its main target IkBa that was
accompanied by a modest increase of active NF-kB p65-
phospho-Ser536 levels. In contrast, specific inhibition of IKK
and down-regulation of NF-kB p65-phospho-Ser536 levels by
BMS345541 (10 mM) were observed (Fig. 3D). Ars2 levels were
increased in parallel to IKK-NF-kB activation and also suppressed
with BMS345541, further highlighting a possible NF-kB-depen-
dent manner of regulation of Ars2 expression. In contrast, Sox2
Fig. 1 – Effects of sodium arsenite treatment on growth and survival of human neural stem cells (NSC). (A, B, E and F) Confocal
analysis of immunofluorescent images of NSC was performed using monoclonal antibody against nestin, an early
neuroprogenitor cell marker (red), and polyclonal antibody against Sox2, a pluripotency marker (green). (C and D) Determination
of human NSC growth and survival was performed in the absence or in the presence of increased doses of sodium arsenite
(1–4 lM). Sodium arsenite was added to NSC cultures at the logarithmic phase (panels A and C) or at 70% confluency (panels B
and D) at day 0 for the next 3 days. Numbers of live cells attached to fibronectin matrix were determined. Pooled results of five
independent experiments are shown in panels C and D. Error bars represent meansþSD. Statistically significant differences in cell
number between control and arsenite treated (1–4 lM) cell cultures are indicated by the stars. Statistically significant differences
in cell survival between cell cultures treated with 4 lM arsenite, compared to cultures treated with 1 lM arsenite, are indicated
by the triangles (po0.05, Student’s t-test). Images of control NSC and surviving NSC 48 h after sodium arsenite exposure are
shown on panels E and F.
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did not respond to IKK inhibition (Fig. 3D). Sox2, which was
upregulated 6 h after arsenite treatment, returned to relatively
stable levels after prolonged 16-h arsenite exposure (Fig. 4C).
Immunostaining with anti-Sox2 Ab further confirmed this obser-
vation: nuclear levels of Sox2 were relatively stable in surviving
cells, while the total number of attached cells notably decreased
24 h after arsenic treatment (see Fig. 1E and F).
A decrease in phospho-(Ser473)–AKT levels after extended treat-
ment (16 h) of NSC with arsenite was followed by a modest decrease
in b-catenin levels that was more pronounced after combined
treatment of arsenite and LY294002, a PI3K–AKT inhibitor
(Fig. 4A). Furthermore, extended arsenite exposure of NSC resulted
in a cytochrome-c release from mitochondria to cytosol, and heme-
induced upregulation of heme oxygenase-1 (HO-1), a protective
enzyme with a general anti-apoptotic activity. Addition of IGF1 (as a
strong inducer of PI3K–AKT) 30 min before arsenite to cell cultures
blocked cytochrome-c release and HO-1 activation (Fig. 4B), resulting
in suppression of apoptotic commitment. Activation of p53 (via
Ser20 phosphorylation) was a characteristic feature of sodium
arsenite treatment of NSC at relatively low doses (1–2 mM)
(Fig. 3C). Finally, caspase-9 cleavage and activation was followed
by caspase-9/caspase-3 directed apoptosis, including a cleavage of
PARP-1 (Fig. 4C). Immunostaining of mitochondrial pyruvate dehy-
drogenase further demonstrated a pronounced down-regulation of
levels of this critical enzyme after sodium arsenite exposure,
reflecting damage of mitochondria (Fig. 4D). Annexin-V-FITC and PI
staining independently confirmed arsenite-induced apoptotic com-
mitment of NSC and enhancing effects of PI3K–AKT inhibition on
Fig. 2 – Dose-dependent effects of sodium arsenite treatment on induction of apoptosis in human NSC. (A) Phase contrast
microscopy of human NSC (cultured as adherent cells) in the absence and in the presence of 4 lM sodium arsenite, 48 h of
exposure. (B) Cell cycle-apoptosis analysis of human NSC 24–48 h after treatment by sodium arsenite (2–6 lM). Cells were stained
by propidium iodide and analyzed by flow cytometry. A typical experiment (one of four) is presented. Determination of total cell
death levels 48 h after sodium arsenite treatment was performed using Trypan blue staining.
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arsenite-induced cell death levels, when apoptosis was followed by
increasing levels of secondary necrosis (Fig. 4E). In summary,
pronounced proapoptotic effects of sodium arsenite exposure for
human NSC were observed, due to activation of the caspase-9/
caspase-3-dependent mitochondrial apoptotic pathway and a partial
suppression of the protective PI3K–AKT pathway.
Effects of combined treatment of sodium arsenite with
small molecule inhibitors on cell survival and apoptosis of
NSC
To further determine a differential role of signaling pathways in
modulating effects of sodium arsenite on cell cycle and apoptosis of
NSC, we used small molecule inhibitors, alone or in combination
with sodium arsenite (Fig. 5). Inhibition of PI3K–AKT and IKK–NF-kB
by LY294002 and BMS345541, respectively, induced pronounced
apoptosis in NSC 24 h after treatment (Fig. 5A), while inhibition of
MEK–ERK by U0126 and JNK by SP600125 did not demonstrate a
notable proapoptotic response. PARP-1 cleavage further confirmed
caspase-3-dependent apoptosis induced either by sodium arsenite,
or by LY294002 and BMS345541. In contrast, SP600125 and U0126
did not induce PARP-1 cleavage (Fig. 5C). Both a pan-caspase
inhibitor zVAD-fmk (50 mM) and a caspase-9 inhibitor Ac-LEHD-
CHO (50 mM) suppressed arsenite-induced apoptosis (Fig. 5B).
Combined treatment with arsenite (2 mM) and LY294002 (40 mM),
or with arsenite and BMS345541 (10 mM) further increased the
Fig. 3 – Effects of sodium arsenite treatment on the main signaling pathways in human NSC. (A, C and D) Signaling proteins and
transcription factors were detected using Western blot analysis 6 h after treatment with increased doses of sodium arsenite, alone or in
combination with SP600125 (20 lM) and BMS345541 (10 lM). A ratio of phospho-protein/total protein is indicated for ERK, cJun, STAT3
and AKT. A ratio protein/actin is indicated for nestin, SOX2 and ARS2. (B) Analysis of immunofluorescent images of non-treated (control)
and sodium arsenite (4 lM) treated NSC. Cells were stained with anti-phospho-ERK (green) and anti-nestin (red) Abs. (For interpretation
of the references to color in this figure legend, the reader is referred to the web version of this article.)
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proapoptotic response of human NSC 24–48 h after treatment
(Fig. 5B). In contrast, suppression of JNK activity by SP600125
(20 mM) decreased levels of arsenite-induced apoptosis (Fig. 5B),
highlighting a pro-apoptotic balance of JNK activation after arsenite
treatment of NSC (Fig. 3A). Immunostaining of human NSC after
combined treatment with arsenite and LY294002 or BMS345541
strongly demonstrated a decreased number of surviving cells
attached to the laminin matrix (Fig. 5D).
Taken together, these data further demonstrated proapoptotic
features of arsenite treatment in human NSC based induction of
the mitochondrial death pathway in concert with suppression of
PI3K–AKT and activation of JNK (mostly, JNK1) accompanied by
phosphorylation of cJun, which could also be involved in acceleration
of the mitochondrial apoptotic pathway [24]. However, there was a
profound difference in regulation of expression of Sox2 in human
NSC compare to ESC linked with the absence of negative effects of
low doses of arsenite on Sox2 protein levels in NSC. In contrast,
Nanog protein levels were significantly down-regulated in both
mouse ESC (data not shown) and human NSC after extended sodium
arsenite treatment (see Fig. 4C).
Alteration of neuronal differentiation of human NSC in
the presence of sodium arsenite
Removing FGF2 and EGF from the NSC media induced neuronal
differentiation of human NSC (Fig. 6) that was accompanied by
Fig. 4 – (A–C) Signaling proteins and transcription factors were detected using Western blot analysis 16 h after treatment with
increased doses of sodium arsenite, alone or in combination LY294002 (40 lM) and IGF1 (40 ng/ml). Determination of
cytochrome-c levels (panel B) was performed in cytosol, while total protein extract was used for all other cases. (D)
Immunostaining of mitochondrial pyruvate dehydrogenase (red) in the control and arsenite-treated NSC. The nuclei were
stained by DAPI (blue). (E) Annexin-V-FITC and PI staining of control and arsenite (As) treated NCS was followed by FACS analysis.
The percentages of necrotic, late-apoptotic and early-apoptotic cells are indicated. (For interpretation of the references to color
in this figure legend, the reader is referred to the web version of this article.)
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high levels of cell death. The gradual disappearance of an early
neuroprogenitor cell marker, nestin (red), which was substituted
with neuro-specific marker, doublecortin (green) was evident in
surviving cells (Fig. 6). The presence of sodium arsenite at
dose 2 mM and especially at 4 mM significantly retarded this
process with a dramatic decrease in a green/red ratio (a ratio
of the number of doublecortin-positive green cells to the number
of nestin-positive red cells) and in a relative cell survival.
Average cell survival of control or arsenite-treated differentiating
cells was determined by direct counting cells that were
attached to the laminin matrix in six microscopic areas 10 days
after initiation of differentiation using immunostaining. Survival
of control differentiating cells (in the absence of sodium arsenite)
was referred to as 100% (Fig. 6). Substantially increased levels of
phospho-JNK were also observed in sodium arsenite-treated
cells (Fig. 6, right panel). As expected, numerous apoptotic nuclei
were detected in differentiating cell cultures. The initial cell
density of NSC could affect the rate of neuronal differentiation,
which was down-regulated in conditions of high confluency
(Supplementary Fig. 1A and B). On the other hand, negative
Fig. 5 – Effects of combined treatment of small molecule inhibitors and sodium arsenite on cell cycle and apoptosis of human
NSC. (A and B) Cell cycle-apoptosis analysis was performed after treatment of human NSC with indicated inhibitors alone or in
combination with 2 lM sodium arsenite. Pan-caspase inhibitor zVAD-fmk (40 lM) and caspase-9 inhibitor LEHD (40 lM) were
also used. PI staining of DNA and FACS analysis were performed 24 h after the indicated treatment. A typical experiment is
presented in panel A; pooled results of four independent experiments are shown in panel B. Error bars represent means7S.D.
(po0.05, Student’s t-test). (C) Western blot analysis of PARP-1 cleavage after indicated treatments of human NSC. Beta-actin was
used as a loading control. (D) Self-renewal of human NSC in the absence (control) and in the presence of sodium arsenite (2 lM)
or in combinations of LY294002 (40 lM) and sodium arsenite (2 lM); BMS345541 (10 lM) and sodium arsenite (2 lM). Confocal
analysis of immunofluorescent image of human NCS was performed using monoclonal antibody against nestin (red) and
polyclonal antibody against Sox2 (green). Relative cell survival is indicated. (For interpretation of the references to color in this
figure legend, the reader is referred to the web version of this article.)
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effects of arsenite on cell survival during differentiation were
less pronounced in the confluent culture (Supplementary
Fig. 1B), probably due to increased endogenous production of
surviving factors.
Inhibition of PI3K–AKT activation by small molecule inhibitors
during neuronal differentiation is similar with negative effects of
arsenite, which also suppresses AKT activity and substantially
down-regulates neuronal differentiation. A combination of
LY294002 and arsenite strongly decreased both relative cell
survival and levels of the neuronal differentiation (Fig. 7). On
the other hand, increased expression of phospho-ERK
(Supplementary Fig. 2) and phospho-JNK (Fig. 6) were observed
among differentiating cells following arsenite exposure. The
question arose regarding the downstream effects of sodium
arsenite-induced upregulation of ERK1/2 and JNK1 activities on
regulation of neuronal differentiation.
Suppression of basal ERK1/2 or JNK activity with U0126
(10 mM) and SP600125 (20 mM), respectively, modestly
retarded neuronal differentiation of NSC in the differentiation
media (Fig. 8A and B). On the other hand, while inhibition of
arsenite-induced ERK activity with U0126 modestly recovered
differentiation of NSC, inhibition of arsenite-induced JNK
activity with SP600125 resulted in massive cell killing with a
substantially decreased yield of differentiating neurons
(Fig. 8B). Interestingly, such a positive summary role of
arsenite-induced JNK activation during neuronal differentia-
tion was opposite to its proapoptotic role during arsenite
treatment of human NSC (Fig. 5B). Hence, optimal levels of
ERK activity were important for regulation of NSC prolifera-
tion, while overexpression of active ERK induced by sodium
arsenite could partially suppress the normal pathway of neural
differentiation. On the other hand, JNK activation was involved
in numerous functions during neuronal differentiation [25,26]
and inhibition of its activity either during normal differentia-
tion or, especially, during arsenite exposure of neural progeni-
tors resulted in upregulation of cell death and an additional
suppression of neuronal differentiation (Fig. 8). Phosphory-
lated cJun, one of the main targets of JNK, could also be
involved in transcriptional regulation of both apoptotic com-
mitment and neuronal differentiation.
Taken together, results obtained demonstrated aggressive
cytotoxic action of sodium arsenite (even at low doses such as
2–4 mM) that substantially disturbed normal neuronal differen-
tiation of human NSC.
Fig. 6 – Neuronal differentiation of human NSC. Neuronal differentiation was initiated in the absence or in the presence of
2–4 lM sodium arsenite. Confocal analysis of immunofluorescent image was performed using monoclonal antibody against an
early neuroprogenitor marker, nestin (red), and neuronal marker, doublecortin (green). The NSC before initiation of
differentiation at day 0 and two representative images, (1) and (2), of each variant after 10 days of differentiation are shown.
A ratio of the number of green cells to the number of red cells and a relative cell survival (10 days after initiation of
differentiation) is indicated. The right column demonstrates arsenite-induced JNK activation determined with anti-JNK-P Ab and
DAPI staining of the nuclei. The white arrows indicate apoptotic nuclei.
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Discussion
The results of the present study demonstrated that sodium arsenite
treatment negatively regulated survival of human NSC by induction
of the mitochondrial apoptotic pathway (Supplementary Fig. 3).
Furthermore, the simultaneous suppression of the protective
PI3K–AKT pathway further increased levels of cell death in NSC
after sodium arsenite exposure. A pivotal role of PI3K–AKT in
regulation of survival and self-renewal of pluripotent embryonic
stem cells and multipotent neural stem cells has previously been
reported [27–29]. AKT-dependent suppression of GSK3b activity
that resulted in stabilization of protein levels of b-catenin was one
of the essential events in regulation of proliferation and survival of
human NSC [30]. Additionally, the PI3K–AKT pathway controls
numerous cell functions, including activation of mTOR and general
protein synthesis [31], and inactivation of proapoptotic activity of
FOXO3A [23] that was also observed following sodium arsenite
treatment of human NSC (see Fig. 3A and Supplementary Fig. 3).
We demonstrated in the present study that arsenite-induced
mitochondrial damage accompanied by cytochrome-c release
and caspase-9/caspase-3-dependent apoptosis substantially
decreased a population of human multipotent NSC, even at low
doses of sodium arsenite (2–4 mM). Negative effects of arsenite
exposure on some additional downstream targets of the
PI3K–AKT pathway, including Nanog protein levels in NSC, were
further determined in the present study (Fig. 4C; see also
Supplementary Fig. 3). Paradoxically, there was a significant
difference in regulation of protein expression levels of Sox2 in
ESC versus NSC after arsenite treatment. We observed a strong
dose-dependent down-regulation of Sox2 (in concert with Oct4
and Nanog) in mouse ESC (Ivanov and Hei, non-published data)
Fig. 7 – Effects of treatment with sodium arsenite alone or in combination with LY294002 (40 lM) on neuronal differentiation of
human NSC. Neuronal differentiation of NSC was performed in the differentiation medium in the absence or in the presence of
2–4 lM sodium arsenite, LY294002 or their combination. Confocal analysis was performed using Abs against nestin (red) and
doublecortin (green). A ratio of the number of green (doublecortin-positive) cells to the number of red (nestin-positive) cells and
a relative cell survival after 10 days are indicated.
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and relatively stable Sox2 protein levels, but strongly decreased
Nanog levels in NSC 16–48 h after arsenite treatment (Figs. 3 and
4). Accordingly, immunostaining arsenite-treated NSC demon-
strated that surviving cells exhibited pronounced protein expres-
sion of Sox2 (Fig. 1A and B). Interestingly, expression levels of
Ars2, that was recently considered as a transcriptional regulator
of Sox2 [15], were actually upregulated in the presence of
arsenite (Fig. 3D). Our data indicated an AKT- and IKK/NF-kB-
independent, but JNK/cJun-dependent manner of Sox2 expres-
sion in NSC. It could be a result of changes in transcription factor
binding by the Sox2 promoter, for example, from Oct4 in ESC to
Oct1 in NSC [21,32] with the subsequent changes in regulation of
the Sox2 promoter activity by arsenite exposure.
Besides negative regulation of PI3K–AKT, down-regulation of
IKK–NF-kB and JAK2–STAT3, activities by arsenite is a well-
documented phenomenon for many normal and cancer cells [33].
However, arsenite (1–2 mM) treatment of NSC actually upregulated
levels of active IKK–NF-kB, probably, due to increased production of
endogenous cytokines, such as TNFa [34] that is known as an
inducer of NF-kB. The absence of arsenite-induced Stat3 down-
regulation in NSC could also be a result of its compensatory
activation due to the endogenous cytokine production.
In summary, we demonstrated that arsenite exposure could
dramatically change survival of NSC through induction of a
massive apoptotic death. A question arose regarding quality
and specificity of the neuronal differentiation of multipotent
human NSC in the absence or in the presence of sodium arsenite.
Our data revealed that neuronal differentiation of human NSC,
which was initiated by FGF2 and EGF withdrawal, was strongly
disturbed in the presence of 2–4 mM arsenite, including pro-
nounced morphological changes, a decrease in cell survival and a
dramatic decrease in yield of differentiated cells (Fig. 6). These
negative effects could be further enhanced by an additional
inhibition of the PI3K–AKT pathway using LY294002 (Fig. 7).
On the other hand, basal levels of JNK activity were linked with
regulation of neural differentiation [25], and a suppression of
basal and arsenite-induced JNK activation by specific inhibitor
SP600125 resulted in suppression of differentiation and acceler-
ated death of neural progenitor cells (Fig. 8). Arsenite-induced
ERK activation during neuronal differentiation appeared to play
the opposite role and actually increased proapoptotic commit-
ment and suppressed differentiation. Consequently, its inhibition
resulted in some protective effects during arsenic exposure of
neural progenitor cells (Fig. 8). Interestingly, the recent study
Fig. 8 – Effects of inhibition of sodium-arsenite-induced ERK and JNK1 activation on neuronal differentiation of human NSC.
(A) NSC before induction of differentiation. (B) Neuronal differentiation of NSC was performed in the differentiation medium in
the absence or in the presence 2 lM sodium arsenite, U0126 (10 lM), SP600125 (20 lM) or their combinations. Cell markers
determined by immunostaining are indicated. A ratio of the number of green (doublecortin-positive) cells to the number of red
(nestin-positive) cells and a relative cell survival after 10 days are indicated.
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demonstrated that ERK inhibition by small molecule inhibitor of
MEK–ERK rescued NF1-deficient neural progenitors (with
strongly increased MEK–ERK activity leading to increased glio-
genesis) from defects in fate specification and restored neuro-
genesis [35]. Beside JNK–cJun, the Notch pathway is critically
involved in positive regulation of neural differentiation and
suppression of proliferation in NSC [24]. Sodium arsenite was
recently determined as an effective inhibitor of Notch signaling
in normal human cells [36]. Inhibitory functions of sodium
arsenite for the Notch signaling pathway need to be proved in
NSC and neural progenitor cells.
We expect that investigation of signal-dependent regulation of
gene expression driven by key transcription factors and mod-
ulating effects of sodium arsenite on gene expression in stem
cells may open up new opportunities for understanding mechan-
isms of arsenic-mediated neurotoxicity.
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